iiinova — where your digital self keeps evolving

Reposted by Oliver Tavabie

Chris Mysko @chrismysko.bsky.social · 09/02/2026

Delighted to share the evolution of @torchuk.bsky.social and our lessons learnt as a road map 🗺️ 🏥 Such a pleasure to work with talented colleagues across the UK to shape this and prime our project pipeline to improve outcomes in liver disease doi.org/10.1136/flga... #liversky #gastrosky #EVADE

132

Reposted by Oliver Tavabie

ToRcH-UK @torchuk.bsky.social · 25/09/2025

📣 Our next project #EVADE is officially LIVE! 📣 Site registration is open to hospitals across the UK. Project dashboard: redcap.link/evade But what is #EVADE and why should you be interested in collaborating with us? #liversky #gastrosky @otavabie.bsky.social @chrismysko.bsky.social (1/6)

131

Oliver Tavabie @otavabie.bsky.social · 17/09/2025

Read our new work developing a patient reported experience survey for outpatients with liver disease and the accompanying feasibility study! Significant challenges remain to improve liver patient participation in surveys #liversky fg.bmj.com/content/earl...

030

Oliver Tavabie @otavabie.bsky.social · 28/05/2025

It was a real pleasure to interview Scott Isaacs and @paulnbrennan.bsky.social regarding their recent paper on 'Anti-diabetic medications in MASLD' in Frontline Gastroenterology - listen below fgbmj.podbean.com/e/role-of-anti-diabetic-medications-in-the-management-of-masld/

fgbmj.podbean.com

Role of anti-diabetic medications in the management of MASLD | FG Podcast

The use of anti-diabetic medications such as pioglitazone or GLP-1 receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease (MASLD) is discussed in this podcast....

161

Reposted by Oliver Tavabie

Feather Moore@medsky.network @feathermoore.bsky.social · 21/05/2025

This overview summarizes clinical tools that assess nutritional status and physical frailty, with the benefits and future challenges of a multidisciplinary team approach to optimise muscle health and physical fitness in patients with decompensated cirrhosis. fg.bmj.com/content/earl...

021

Reposted by Oliver Tavabie

The Baveno Cooperation: an EASL Consortium @bavenocoop.bsky.social · 05/05/2025

🇳🇱 Join us at #EASL2025 in Amsterdam 🇳🇱 📅 Thu 08 May 08:30–09:45 | Future of Hepatology: Endohepatology 10:00–10:30 | Baveno @ EASL Track Hub (Cirrhosis & Complications) 📅 Fri 09 May 12:00–13:30 | Baveno General Assembly (Room D201, members only) #LiverTwitter

054

Oliver Tavabie @otavabie.bsky.social · 05/05/2025

Am looking forward to the ILC this week - not just to catch up with the community but to look for submissions to Frontline Gastroenterology. Do get in contact with me if you want to talk about your work and ideas for manuscripts! #Liversky @easlnews.bsky.social @bavenocoop.bsky.social

000

Reposted by Oliver Tavabie

Oliver Tavabie @otavabie.bsky.social · 16/04/2025

Fantastic to see the updated BSG/BASL decompensated cirrhosis admission bundle in print at FG - practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter fg.bmj.com/content/earl...

fg.bmj.com

Decompensated cirrhosis: an update of the BSG/BASL admission care bundle

Acute decompensated cirrhosis (DC) and acute-on-chronic liver failure are common reasons for hospital admission that have a high in-hospital mortality rate (10%–20%). Patients require a detailed asses...

0116

Oliver Tavabie @otavabie.bsky.social · 16/04/2025

fg.bmj.com

Decompensated cirrhosis: an update of the BSG/BASL admission care bundle

0116

Reposted by Oliver Tavabie

Oliver Tavabie @otavabie.bsky.social · 08/04/2025

Great to see our paper examining real-world applicability of telemonitoring interventions published in FG! Fantastic working with Dee Kumar, Kohi Gananandan, @jennieclough.bsky.social and Guy Robinson on this! #livertwitter #gitwitter fg.bmj.com/content/early/2025/04/08/flgastro-2024-102997

172

Reposted by Oliver Tavabie

Pierre Gholam MD @livermd.bsky.social · 10/04/2025

Time for the liver community to say it loudly, nonjudgementally & consistently: There is no safe level of alcohol consumption @easlnews.bsky.social is leading the way to defend mandatory labels on alc. beverages in the EU. It’s time for @aasldnews.bsky.social to do the same in the US #liversky

031

Oliver Tavabie @otavabie.bsky.social · 08/04/2025

172

Reposted by Oliver Tavabie

Elliot Tapper @ebtapper.bsky.social · 04/04/2025

Let’s talk about sex journals.lww.com/hepcomm/full... #liversky

093

Oliver Tavabie @otavabie.bsky.social · 31/03/2025

Thanks to all that completed the first round of the UK CLIF JLA research priority setting process for decompensated cirrhosis - if you live with or care/work with patients with cirrhosis - please take some time to go through these research questions #livertwitter www.surveymonkey.com/r/SMMF6XJ

surveymonkey.com

Survey: Priorities for Liver Cirrhosis Research

Take this survey powered by surveymonkey.com. Create your own surveys for free.

031

Oliver Tavabie @otavabie.bsky.social · 03/03/2025

Great to see #JadeKing any my editorial in @LTxJournal journals.lww.com/lt/citation/... discussing the psychological and cognitive impact of liver disease and transplantation on patients as well as the potential role of prehabilitation in addressing this #liversky

journals.lww.com

The long and winding road to maximize the benefit of Liver... : Liver Transplantation

An abstract is unavailable. This article is available as a PDF only.

120

Reposted by Oliver Tavabie

Elliot Tapper @ebtapper.bsky.social · 13/02/2025

Lieber is a liver leader We want our patients to thrive after transplant She advocates for tailored, enriched POST transplant care for people at risk of poor outcomes And it is about time #liversky

041

Oliver Tavabie @otavabie.bsky.social · 14/12/2024

x.com/frontgastro_... frontline Gastroenterology isn’t on Bluesky yet but see our Xmas webinar about what authors, reviewers and editors may want for Xmas #liversky #gisky

x.com

000

Oliver Tavabie @otavabie.bsky.social · 23/11/2024

Run cancelled this morning, winter is here…

100

Reposted by Oliver Tavabie

Ewan Forrest @ewanforrest.bsky.social · 20/11/2024

Pleased to see the publication of our paper showing effective management of alcohol withdrawal syndrome in patients with coexistent alcohol-related liver disease using GMAWS. Great contributions by our medical students: Stroma Harcombe, Lujine Ibrahim, Georgia Smith and Alex Doyle. t.co/fEjeZChSVI

052